Next Article in Journal
A Review of the Patterns of Docetaxel Use for Hormone-Resistant Prostate Cancer at the Princess Margaret Hospital
Previous Article in Journal
Systemic Therapies in Metastatic Non-Small-Cell Lung Cancer with Emphasis on Targeted Therapies: The Rational Approach
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 17
Issue 2
10.3747/co.v17i2.498
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Febrile Neutropenia Rates with Adjuvant Docetaxel and Cyclophosphamide Chemotherapy in Early Breast Cancer: Discrepancy between Published Reports and Community Practice—A Retrospective Analysis

by
T. Vandenberg
*,
J. Younus
and
S. Al-Khayyat
Ted Vandenberg, London Regional Cancer Program, 790 Commissioners Road E, Room A3-920, London, ON N6A 4L6, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2010, 17(2), 2-3; https://doi.org/10.3747/co.v17i2.498
Submission received: 1 March 2010 / Revised: 3 March 2010 / Accepted: 6 March 2010 / Published: 1 April 2010

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Adjuvant therapies, including chemotherapy [...]
Keywords: febrile neutropenia; breast cancer; adjuvant chemotherapy febrile neutropenia; breast cancer; adjuvant chemotherapy

Share and Cite

MDPI and ACS Style

Vandenberg, T.; Younus, J.; Al-Khayyat, S. Febrile Neutropenia Rates with Adjuvant Docetaxel and Cyclophosphamide Chemotherapy in Early Breast Cancer: Discrepancy between Published Reports and Community Practice—A Retrospective Analysis. Curr. Oncol. 2010, 17, 2-3. https://doi.org/10.3747/co.v17i2.498

AMA Style

Vandenberg T, Younus J, Al-Khayyat S. Febrile Neutropenia Rates with Adjuvant Docetaxel and Cyclophosphamide Chemotherapy in Early Breast Cancer: Discrepancy between Published Reports and Community Practice—A Retrospective Analysis. Current Oncology. 2010; 17(2):2-3. https://doi.org/10.3747/co.v17i2.498

Chicago/Turabian Style

Vandenberg, T., J. Younus, and S. Al-Khayyat. 2010. "Febrile Neutropenia Rates with Adjuvant Docetaxel and Cyclophosphamide Chemotherapy in Early Breast Cancer: Discrepancy between Published Reports and Community Practice—A Retrospective Analysis" Current Oncology 17, no. 2: 2-3. https://doi.org/10.3747/co.v17i2.498

APA Style

Vandenberg, T., Younus, J., & Al-Khayyat, S. (2010). Febrile Neutropenia Rates with Adjuvant Docetaxel and Cyclophosphamide Chemotherapy in Early Breast Cancer: Discrepancy between Published Reports and Community Practice—A Retrospective Analysis. Current Oncology, 17(2), 2-3. https://doi.org/10.3747/co.v17i2.498

Article Metrics

Back to TopTop